entity

multi-target drugs

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about multi-target drugs: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2Connections
0Hypotheses
0Analyses
2Outgoing
0Incoming

Wiki Pages (20)

Knowledge base pages for this entity

SNCA→Alpha-synuclein→Aggregation→Lewy Bodies→Synucleinopathies Causal Chain

pathway · 3707 words

Rotigotine and Rivastigmine Combination Therapy for Alzheimer's Disease (NCT06702124)

clinical · 3657 words

Alpha-Synuclein ESCRT-III Inhibition Mechanism

mechanism · 3574 words

Ion Channel Dysfunction in Parkinson's Disease

mechanism · 3382 words

Shared Proteinostasis Failure in Alzheimer's and Parkinson's Disease

mechanism · 3143 words

Outgoing (2)

TargetRelationTypeStr
Alzheimer's diseasetreatsdisease0.70
Alzheimer's diseaseregulatesdisease0.70

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found